Golden
Bill & Melinda Gates Foundation

Bill & Melinda Gates Foundation

Bill & Melinda Gates Foundation operates as a non-profit organization that focuses on healthcare, poverty, and educational sectors in developing countries.

Company Overview

The organization provides grants for agricultural development, global health, and technical education programs. Bill & Melinda Gates Foundation was formerly known as William H. Gates Foundation and changed its name in 2000. The organization was founded in 1994 and is headquartered in Seattle, Washington.

History

The Bill & Melinda Gates Foundation is a grant-making foundation that supports initiatives in education, world health and population, and community giving in the Pacific Northwest. In its local region, the foundation promotes strategies and programs that help low-income families. The Bill & Melinda Gates Foundation was co-founded by Bill Gates and Melinda Gates in 2000 and is based in Seattle, Washington, with regional offices in Washington, D.C.; New Delhi, India; Beijing, China; and London, United Kingdom. Its trustees are Bill and Melinda Gates, and Warren Buffett.

The Bill & Melinda Gates Foundation is a partner of the Global Fund, provides cash contributions, participates on its board and committees, and supports the Global Fund's advocacy, communications and fundraising efforts.

The Gates Foundation has contributed US$2 billion to the Global Fund as of January 2018, and pledged US$600 million for the Global Fund's Fifth Replenishment, covering 2017-2019. This includes US$132 million in matching funds with the United Kingdom's private sector malaria matching challenge, and up to US$100 million to unlock other private sector contributions, including funds that go through (RED). The Gates Foundation and other foundations are represented on the Global Fund Board through the private foundations delegation.

The main mission of the foundation is to make advances in:.

  • Discover new insights to fight diseases and other health problems affecting developing countries.
  • Develop effective and affordable vaccines, medicines, and other health tools.
  • Deliver health solutions.

The foundation's Global Health Program that accounts for about 50 percent of total spending focuses on 20 diseases. The top five are: diarrheal diseases (including rotavirus), pneumonia, malaria--most deadly to kids--and AIDS and TB, which mostly affect adults.

The Bill & Melinda Gates Foundation supports advocacy efforts to build awareness of global health challenges, develop new ways to finance health programs, and improve health data.

Investments

Bill & Melinda Gates Foundation has made 93 investments. One such investment was on Jan 29, 2019, when they invested $55M in Lyndra Therapeutics. Bill & Melinda Gates Foundation has had 14 exits which include Novartis, Moderna Therapeutics, and Synlogic. Bill & Melinda Gates Foundation has $43M in revenue annually and it competes with Carnegie Corporation of New York, Open Society Foundations, and Lumina Impact Ventures.

The Gates Foundation has funded many of the Friends of the Global Fund organizations as well as advocacy partners in both developing and developed countries. The foundation provided support to develop and launch initiatives like Debt2Health and (PRODUCT)RED. The foundation has also funded special initiatives in the health supply chain related to the Global Fund.

Timeline

February 2020

The Bill & Melinda Gates Foundation commits up to $100 million to help fight against the Corona virus.

September 17, 2019

The Bill & Melinda Gates Foundation launches its third annual Goalkeepers Data Report.

January 2018

The Gates Foundation has contributed US$2 billion to the Global Fund as of January 2018, and pledged US$600 million for the Global Fund's Fifth Replenishment, covering 2017-2019.

Funded Companies

Company
Description
Website
Industry
Location

A company developing antibody-based biological medicines for kidney diseases and other chronic diseases. Visterra was acquired by Otsuka Pharmaceutical in 2018.

A biotechnology company that develops medicines based on live bacterial consortia that can colonize the human intestine.

Evolve Biosystems is a company developing a consumer product, Evivo, that improves infants' gut health.

A biopharmecutical company developing human antibody based therapies

Butterfly Network is a company developing and designing a medical imaging device for real-time and three-dimensional or 3D imaging and treatment.

BetterLesson is a Cambridge, Massachusetts-based company.

A company developing targeted monoclonal antibody immunotherapies for the treatment of infectious diseases

A company developing diagnostic platforms such as test for HIV/AIDS and cell counting

CropIn Technology Solutions is an India-based business analytics company founded by CropIn Technology.

Lyndra Therapeutics is a Watertown, Massachusetts-based company.

Stellapps is an India-based company.

13 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn
+ Add new row

Further reading

Title
Author
Link
Type
Date
+ Add new row

Documentaries, videos and podcasts

Title
Date
Link
+ Add new row

Companies

Company
CEO
Location
Products/Services
+ Add new row

News

Title
Author
Date
Publisher
Description
April 5, 2020
The Economic Times
A new 21-year old case reported in Dharavi, Asia's largest slum. Air Deccan is ceasing all its operations until further notice, all employees of the airline to go on sabbatical without pay.
April 2, 2020
WebWire
Pfizer Inc. (NYSE: PFE) today announced the election of Dr. Susan Desmond-Hellmann to its Board of Directors, effective immediately. Dr. Desmond-Hellmann, age 62, was also appointed to the Governance & Sustainability Committee and the Science and Technology Committee of Pfizer's Board. Dr. Desmond-Hellmann served as Chief Executive Officer of the Bill & Melinda Gates Foundation from 2014 until 2020, where she oversaw the creation of the Gates Medical Research Institute--the world's first n...
March 30, 2020
WebWire
Today, the partners in the COVID-19 Therapeutics Accelerator announced grants of $20 million to three institutions--the University of Washington, University of Oxford, and La Jolla Institute for Immunology--to fund clinical trials in order to identify highly potent immunotherapies for the COVID-19 pandemic. These grants mark the first investments to come from the COVID-19 Therapeutics Accelerator, a large-scale initiative launched by the Bill & Melinda Gates Foundation, Wellcome, and Masterc...
Rob Thubron
March 27, 2020
TechSpot
In a Facebook post, CEO Zuckerberg wrote that he and wife Priscilla were committing $25 million to accelerate the development of treatments for Covid-19. The money comes from The Chan Zuckerberg Initiative (CZI) and will be given to the Covid-19...
Jay Peters
March 27, 2020
The Verge
The Chan Zuckerberg Initiative has committed $25 million to a research fund designed to help identify and develop treatments for the disease caused by the novel coronavirus.
Chris Ciaccia
March 19, 2020
Fox News
Microsoft co-founder Bill Gates said a potential shutdown of a country could last between 6 and 10 weeks if all goes well, amid the coronavirus pandemic.
Jennifer Allen
March 16, 2020
feedproxy.google.com
He plans on prioritising his philanthropic endeavours instead.
Jonathan Stempel
March 14, 2020
U.S.
Warren Buffett's Berkshire Hathaway Inc said on Friday that former American Express Co Chief Executive Officer Kenneth Chenault has been nominated to the conglomerate's board of directors, replacing Microsoft Corp co-founder Bill Gates.
March 14, 2020
The Economic Times
The 64-yr-old tech titan on Saturday stepped down from the boards of MS, Berkshire Hathaway.
Louis Casiano
March 14, 2020
Fox News
Microsoft's billionaire co-founder, Bill Gates, is stepping down from the company's board of directors to focus more oh his philanthropic initiatives, Gates announced Friday.
March 11, 2020
WebWire
The Bill & Melinda Gates Foundation, Wellcome and Mastercard committed up to $125 million in seed funding to speed-up the response to the COVID-19 epidemic by identifying, assessing, developing, and scaling-up treatments. The partners are committed to equitable access, including making products available and affordable in low-resource settings. The COVID-19 Therapeutics Accelerator will play a catalytic role by accelerating and evaluating new and repurposed drugs and biologics to treat pat...
March 10, 2020
WebWire
COVID-19 Therapeutics Accelerator will coordinate R&D efforts and remove barriers to drug development and scale-up to address the epidemic. The Bill & Melinda Gates Foundation, Wellcome, and Mastercard today committed up to $125 million in seed funding to speed-up the response to the COVID-19 epidemic by identifying, assessing, developing, and scaling-up treatments. The partners are committed to equitable access, including making products available and affordable in low-resource settings....
Jonathan Shieber
March 10, 2020
TechCrunch
The Bill & Melinda Gates Foundation, Wellcome, and Mastercard announced a new initiative yesterday to accelerate technologies designed to identify, assess, develop, and scale treatments to the COVID-19 epidemic. The COVID-19 Therapeutics Accelerator will evaluate new and repurposed drugs and biologics to treat patients with COVID-19 in the immediate term, and other viral pathogens in [...]
Stephanie Mlot
March 9, 2020
Geek.com
A project funded by the Bill & Melinda Gates Foundation (BMGF) will provide at-home coronavirus testing kits to the people of Seattle. Folks worried they may be infected with COVID-19 can simply swab ...
Economic Times
February 23, 2020
The Economic Times
A third Indian crew on board a cruise ship off the Japanese coast tested positive for the novel coronavirus, taking the total number of Indians infected with COVID-19 to three. The embassy has contacted all three Indian nationals who have tested positive for COVID-19 and are currently receiving treatment at medical facilities.
Kate Kelland
December 5, 2019
IN
The multi-billion dollar philanthropic Bill & Melinda Gates Foundation said on Thursday that its chief executive officer, Sue Desmond-Hellman, is to step down after more than five years, to be replaced by Mark Suzman.
Paige Leskin
June 24, 2019
Business Insider
Tech industry leaders are dating -- and married to -- prominent venture capitalists, models, athletes, and other powerful people.
Makena Kelly
October 2, 2019
The Verge
Melinda Gates has announced a $1 billion commitment over the next decade to promote gender equality in the United States. Gates, who is co-chair of the Bill & Melinda Gates Foundation and founder of the investment firm Pivotal Ventures, penned an op-ed in Time magazine outlining her reasons for making the investment.
Melinda Gates
September 26, 2019
Harvard Business Review
We've never had a chance like this before. Here's how we seize it.
Bill & Melinda Gates Foundation
September 17, 2019
www.prnewswire.com:443
Neue regionale Daten belegen überraschenden und signifikanten Fortschritt, aber es verbleiben große Lücken abhängig von Geschlecht und Geografie SEATTLE, 17....
SHOW MORE

References